Navigation auf uzh.ch
In 2021 ITINERARE has launched its first call for proposals for research grants that will provide bridging funding to ongoing projects involving researchers affiliated to the ITINERARE consortium. Four grants of the duration of 24 months (January 2022 – December 2023) for a total amount of CHF 400'000 have been awarded to projects that are in line with the mission of ITINERARE to foster interdisciplinary translational research in the field of rare disease.
Winning projects
Therapeutic use of CRISPR/Cas9 base editing for the treatment of Vanishing White Matter Disease
Epigenetic changes in remethylation disorders: a novel target
An integrated drug discovery strategy for rare endolysosomal disorders
Bridging the gap between stakeholders in rare disease health care. A qualitative focus group study